Abstract
Tumors developing within a host induce a state of immune tolerance to tumor antigens. Number of concepts are tested in order to activate the antitumoral immune response to recognize and destroy tumor cells. Tumor vaccines genetically modified with cytokine genes (GMTV) are one of strategies currently examined. Different cytokines display different patterns of antitumoral immune response activation but the perfect cytokine or a combination of cytokine are still to be found. Here we present two GMTVs one consisting of cells producing IL-6 and the second producing GM-CSF in a murine tumor rejection model of Renal Cell Carcinoma (RenCa).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ali SA, McLean CS, Boursnell ME, Martin C, Holmes CL, Reeder S et al. Preclinical evaluation of “whole” cell vaccines for prophylaxis and therapy using disabled’ infectious single cycle-herpes simplex virus vector to transduce cytokine genes. 2001Cancer Res.;61: 1663–70
Wang LG, tu DW, Sun Y, Tao Q, Qian S, Mi J, Hamada H, Cao X. The potential antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity. 2001J Cancer Res Clin Oncol127: 101–108
.Porgador A, Tzehoval E, Katz A, Vadau E, Revel M, FeldmanM, Eisenbach LInterleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. 1992Cancer. Res; 52: 3679-86
Mackiewicz A, Wiznerowicz M, Roeb E, Karczewska A, Nowak J, Heinrich PC, Rose-John S. Soluble interleukin 6 receptor is biologically active in vivo. 1995Cytokine7: 14249
.Drakesmith H, O’Neil D, Schneider SC, Binks M, Medd P et al. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and naïve angigen. 1998Proc. Natl. Acad. Sci; 95: 14903-08.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wysocki, P.J., Kowalczyk, D.W., Izycki, D., Grabarczyk, P., Kwias, Z., Mackiewicz, a. (2001). IL-6 and GM-CSF in tumor rejection model of renal cell cancer. In: Mackiewicz, A., Kurpisz, M., Żeromski, J. (eds) Progress in Basic and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 495. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0685-0_55
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0685-0_55
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5194-8
Online ISBN: 978-1-4615-0685-0
eBook Packages: Springer Book Archive